Tricalcium phosphate as an antibiotic vector: A study using a rabbit experimental osteomyelitis implant;Phosphate tricalcique, vecteur d'antibiotiques: Etude sur foyer d'osteomyelite experimentale chez le lapin

Chirurgie

Volumn 123, Issue 6, 1998, Pages 572-579

  Lambotte, J C ^a,b   Thomazeau, H ^a   Cathelineau, G ^b   Lancien, G ^a   Minet, J ^a   Langlais, F ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

DDS; Experimental osteomyelitis; Gentamicin; Norden; TCP

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM PHOSPHATE; GENTAMICIN; VANCOMYCIN;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CERAMICS; DEBRIDEMENT; DRUG DELIVERY SYSTEM; DRUG IMPLANT; EXPERIMENTAL INFECTION; INTRAOSSEOUS DRUG ADMINISTRATION; NONHUMAN; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS; TIBIA;

EID: 0344076106     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-4001(99)80006-3     Document Type: Article

References (50)

1. 1 Bunetel L, Segui A, Langlais F, Cormier, M. Osseus concentrations of gentamicin after implantation of acrylic bone cement in sheep femora. Eur J Drug Metab Pharmacokinet 1994 ; 19 : 99-105
2. 2 Chohfi M, Langlais F, Fourastier J, Minet J, Thomazeau H, Cormier M. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop 1998 ; 22 : 171-7
3. 3 Langlais F. Ciments orthopédiques aux antibiotiques: bilan, risques, avenir. J Pharm Clin 1984 ; 3 : 215-26
4. 4 Langlais F, Bunetel L, Segui A, Sassi N, Cormier M. Antibiotic-loaded cements, pharmacocinetics and concentration in bone. J Orthop Surg 1988 ; 74 : 493-503
5. 5 Langlais F, Cormier M, Bunetel L, Fourastier J, Blanquaert D. Prevention of infection by antibiotic loaded bone cement in major oncological reconstructions. In: Brown K, ed. Complications of Limb Salvage. Montreal: Isols Ed; 1991. p 601-3
6. e Journée de pharmacologie clinique [abstract]. Paris ; 1997. p 1-10
7. 7 Daculsi G, Passuti N, Martin S, Le Nihouannen JC, Brulliard V, Delecrin J et al. Étude comparative de céramiques bioactives en phosphate de calcium après implantation en site spongieux chez le chien. Analyse histologique, ultrastructurale et par microsonde électronique. Rev Chir Orthop 1989 ; 75 : 65-71
8. 8 De Groot K. Bioceramics of Calcium Phosphate. Floride: CRC Press, Boca Raton; 1983
9. 9 De Groot K. Calciumphosphate bioceramics: their future in clinical practice. Rev Eur Tech Biomed 1991 ; 13 : 88-91
10. 10 Frayssinet P, Trouillet JL, Rouquet N, Azimus E, Autefage A. Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition. Biomaterials 1993 ; 14 : 423-9
11. 11 Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 1981 ; 157 : 259-78
12. 12 Bajpai PK, Benghuzzi HA. Ceramic systems for long-term delivery of chemicals and biologicals. J Biomed Mat Res 1988 ; 22 : 1245-66
13. 13 Becker-PL, Smith-RA, Williams-RS, Dutkowsky-JP. Comparison of antibiotic release from polymethylmefhacrylate beads and sponge collagen. J Orthop Res 1994 ; 12 : 737-41
14. 14 Chapman NW, Hadley WK. The effect of polymethyl methacrylate and antibiotic combinations on bacterial viability. An in vitro and preliminary in vivo study J Bone Jt Surg 1976 ; 58A : 76-81
15. 15 Guicheux J, Grimandi G, Trécant M, Faivre A, Takahashi S, Daculsi G. Apatite as carrier for growth hormone: In vitro characterisation of loading and release. J Biomed Mater Res 1997 ; 34 : 165-70
16. 16 Hernigou P, Glorion C, Girard-Pipau F, Deriot H, Goutallier D, Libération in vitro et in vivo des antibiotiques à partir des greffes osseuses [abstract]. Rev Chir Orthop 1992 ; Suppl 1 : 217
17. 17 Laurencin CT, Gerhart T, Witschger P, Satcher R, Domb A, Rosenberg AE et al. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J Orthop Res 1993 ; 11 : 256-62
18. 18 Vasant V Ranade. Drug Delivery Systems: 3A Role of Polymers in Drug Delivery. J Clin Pharmacol 1990 ; 30 : 10-23
19. 19 Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. J Bone Jt Surg 1978 ; 60B : 270-5
20. 20 Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon SH et al. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier. J Bone Jt Surg 1991 ; 73B : 246-52
21. 21 Brouard S, Lelan J, Lancien G, Bonnaure M, Cormier M, Langlais F. Phosphate tricalcique vecteur d'antibiotiques : gentamicine et vancomycine. Caractérisation physicochimique in vitro, étude de la porosité du biomateriau et du relargage de la vancomycine et de la gentamicine. Chirurgie 1997 ; 122 : 397-403
22. 22 Cornell CN, Tynda D, Waller S, Lane JM, Brause BD. Treatment of experimental osteomyelitis with antibiotic impregnated bone graft substitute. J Orthop Res 1993 ; 11 : 619-26
23. 23 Eitenmüller J, Schmidt KH, Peters G. Experimental and preliminary clinical experience with absorbable calcium phosphate granules containing an antibiotic or antiseptic for the local treatment of osteomyelitis. J Hosp Infect 1985 ; 6 (Suppl A) : 177-84
24. 24 Gerhart TN, Roux RD, Hanff PA, Horowitz GL, Renshaw AA, Hayes WC. Antibiotic-loaded biodegradable bone cement for prophylaxis ant treatment of experimental osteomyelitis in rats. J Orthop Res 1993 ; 11 : 250-5
25. 25 Itokazu M, Matsunaga T, Kumazawa S, Oka M. Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block. Clin Mater 1994 ; 17 : 173-9
26. 26 Otsuka M, Yoshihisa M, Yoshiko S, Fox JL, Higuchi W. A novel skeletal drug delivery system using self setting calcium phosphate cement; 2 Physicochemical properties and drug release rate of the cement containing indomethacin. J Pharm Sci 1994; 83: 611-5
27. 27 Prat-Poiret N, Langlais F, Bonnaure M, Cormier M, Lancien G. Phosphate tricalcique et gentamycine. Diffusion de l'antibiotique in vitro et in vivo, réhabitation en site osseux chez le mouton. Chirurgie 1996 ; 121 : 298-308
28. 28 Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delevery system for antibiotics. J Bone Jt Surg 1992 ; 74B : 600-4
29. 29 Thomazeau H, Langlais F. Relargage d'antibiotiques par implantation de phosphate tricalcique. Pharmacocinétique in vitro et in vivo de formes galéniques différentes. Chirurgie 1996 ; 121 : 663-6
30. 30 Yamamura K, Iwata H, Yotsuyanagi T. Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro release testing. J Biom Mater Res 1992 ; 26 : 1053-64
31. 31 Yu D, Tsai CL, Wong J, Fox JL. Hydroxyapatite cement based drug delivery systems: drug release in vitro. J Formos Med Assoc 1991 ; 90 : 10
32. 32 Sorensen TS, Sorensen AI. Bactericidal activity of gentamicin against S aureus. In vitro study questions value of prolonged high concentrations. Acta Odhop Scand 1993 ; 64 : 82-4
33. 33 Daly RC, Fitzgerald RH Jr, Washington JA. Penetration of cefatolin into normal and osteomyetilic canine cortical bone. Antimicrob Agents Chemother 1982 ; 22 : 461-9
34. 34 Hall BB, Fitzgerald RH. The pharmacokinetics of penicillin in osteomyelitic canine bone. J Bone Jt Surg 1983 ; 65-A : 526-32
35. 35 Norden CW. Experimental osteomyelitis: a description of the model. J Infect Dis 1970 ; 122 : 410-8
36. 36 Dahners LE, Funderburk CH. Gentamicin-Ioaded plaster of Paris as a treatment of experimental osteomyelitis in rabbits. Clin Orthop 1987 ; 219 : 278-82
37. 37 Zekeriya U Isiklar, Rabili O Darouicbe, Glenn C Landon, Thomas Beck. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop Rel Res 1996 ; 332 : 184-9
38. 38 Mader JJ, Kenneth A. Comparative of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother 1989 ; 35 : 689-92
39. 39 Mayberry-Carson. Osteomyelitis experimentally induced with bacteroides thetaiotaomicron and staphylococcus epidermides Clin Orthop Rel Res 1992 ; 280 : 289-99
40. 40 Norden CW. Experimental osteomyelitis II. Therapeutic trials and measurement of antibiotic levels in bone. J Infect Dis 1971 ; 124 : 565-71
41. 41 Rodeheaver G, Rukstalis D, Bono M, Bellamy W. A new model of bone infection used to evaluate the efficacy of antibiotic impregnated polymethylmethacrylate cement. Clin Orthop 1983 ; 178 : 303-11
42. 42 Norden CW, Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988 ; 10 : 103-10
43. 43 Sirot J, Lopitaux R, Sirot D, Rampon S, Delisle JJ, Dumont C et al. Étude comparative de la diffusion de la céphadrine, de la tobramycine et de la rifampicine dans le fémur de l'homme. Méd Mal Inf 1978 ; 4 : 152-7
44. 44 Hortin GL, Landt M, Wilhite T, Smith CH. Cross-reactivity of a vancomycin degradation product in three immuno-assays of vancomycin. Clin Chem 1991 ; 37 : 2009
45. 45 Yeo KT, Traverse W, Horowitz GL. Clinical performance of the Emit vancomycin assay. Clin Chem 1989 ; 35 : 1504-7
46. 46 Rosin H, Rosin AM, Krämer J. Determination of bone levels in human bone: Gentamicin levels in bone. Infection 1974 ; 1 : 3-6
47. 47 Fitzgerald RH. Experimental osteomyelitis: description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis. J Bone Jt Surg 1983 ; 65A : 371-80
48. 48 Garvin KL, Miyano JA, Robinson D, Giger D, Novak J, Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis: a canine model. J Bone Jt Surg 1994 ; 76A : 1500-6
49. 49 Mader JT. Animal models of osteomyelitis. Am J Med 1985 ; 78 (Suppl 6b) : 213-7
50. 50 Kaarsemaker S, Walenkamp GHIM, Bogaard A EJ. New model for chronic osteomyelitis with Staphylococcus aureus in sheep. Clin Orthop Rel Res 1997 ; 339 : 246-52